Phosphorylation of PML by mitogen-activated protein kinases plays a key role in arsenic trioxide-mediated apoptosis.
about
PML nuclear bodiesPharmacological inhibition of BMK1 suppresses tumor growth through promyelocytic leukemia proteinFrom an old remedy to a magic bullet: molecular mechanisms underlying the therapeutic effects of arsenic in fighting leukemiaThe SUMO pathway: emerging mechanisms that shape specificity, conjugation and recognition.Identification of arsenic-binding proteins in human breast cancer cellsDifferential interactions of the homeodomain-interacting protein kinase 2 (HIPK2) by phosphorylation-dependent sumoylation.Location of NLS-RARα protein in NB4 cell and nude mice.SUMOylation of HMGA2: selective destabilization of promyelocytic leukemia protein via proteasome.PML-mediated signaling and its role in cancer stem cells.Requirement of PML SUMO interacting motif for RNF4- or arsenic trioxide-induced degradation of nuclear PML isoforms.A novel proteomics approach to identify SUMOylated proteins and their modification sites in human cellsCell cycle arrest and apoptotic cell death in cultured human gastric carcinoma cells mediated by arsenic trioxide.A Phospho-SIM in the Antiviral Protein PML is Required for Its Recruitment to HSV-1 Genomes.Cross talk between PML and p53 during poliovirus infection: implications for antiviral defense.In silico analysis of functional single nucleotide polymorphisms in the human TRIM22 geneMitogen-activated protein kinase extracellular signal-regulated kinase 2 phosphorylates and promotes Pin1 protein-dependent promyelocytic leukemia protein turnover.Acetylation of PML is involved in histone deacetylase inhibitor-mediated apoptosis.Coordinate to guard: crosstalk of phosphorylation, sumoylation, and ubiquitylation in DNA damage response.SUMO deconjugation is required for arsenic-triggered ubiquitylation of PMLPML nuclear bodies: assembly and oxidative stress-sensitive sumoylation.Acute promyelocytic leukemia: a model of molecular target based therapy.Cyclic nucleotide phosphodiesterases as targets for treatment of haematological malignancies.Degradation of the tumor suppressor PML by Pin1 contributes to the cancer phenotype of breast cancer MDA-MB-231 cells.Sumoylation regulates multiple aspects of mammalian poly(A) polymerase functionSequential posttranslational modifications regulate PKC degradation.Post-translational modifications of PML: consequences and implications.Arsenic trioxide disrupts glioma stem cells via promoting PML degradation to inhibit tumor growthPML(NLS(-)) inhibits cell apoptosis and promotes proliferation in HL-60 cells.Treatment of acute promyelocytic leukaemia with all-trans retinoic acid and arsenic trioxide: a paradigm of synergistic molecular targeting therapy.B Cell Linker Protein (BLNK) Is a Selective Target of Repression by PAX5-PML Protein in the Differentiation Block That Leads to the Development of Acute Lymphoblastic LeukemiaNew Strategies to Direct Therapeutic Targeting of PML to Treat CancersSUMO wrestling with Ras.Response of SMRT (silencing mediator of retinoic acid and thyroid hormone receptor) and N-CoR (nuclear receptor corepressor) corepressors to mitogen-activated protein kinase kinase kinase cascades is determined by alternative mRNA splicing.Regulation of apoptosis by PML and the PML-NBs.Induction of promyelocytic leukemia (PML) oncogenic domains (PODs) by papillomavirus.Mitogen-activated protein kinase-mediated licensing of interferon regulatory factor 3/7 reinforces the cell response to virusTargeting promyelocytic leukemia protein: a means to regulating PML nuclear bodiesNLS-RARα promotes proliferation and inhibits differentiation in HL-60 cells.Arsenic trioxide for management of acute promyelocytic leukemia: current evidence on its role in front-line therapy and recurrent disease.Regulation of the tumor suppressor PML by sequential post-translational modifications.
P2860
Q22065791-A1ABE5C3-7687-42ED-A6AE-4D654FDC1A6FQ24299360-DEE799C1-17D4-4BC5-A7EA-85585983B0DEQ24605527-519DB501-F376-4562-A1B1-A2894393B11AQ27865256-1D245C13-892D-4744-914D-0E910FF1A861Q30831628-D327A38A-8C1F-4DE4-A3DB-D6078B760C1FQ33292560-81EF9203-1C48-4C03-AABE-7CCA31C5F44FQ33597873-A2917104-8BA7-4DCB-BC1D-4468BDDD18A9Q33824136-293F59D6-CE42-4BB4-9F78-84DA5595A1CFQ34337626-C91459CD-C568-4857-A5B2-F58AE1336461Q34427740-D724103E-BA1A-4040-AD2C-95D0D0902BF4Q34551874-8AF3BCA6-09BA-4AB6-8FB7-50322B97403BQ34558420-2B19B89E-0806-4B10-87C0-427C4C788DD0Q34774721-2F080922-7764-449B-B274-2832B9B5C81EQ35024144-E9B94C78-A987-4683-92FC-4BCE817E4DE4Q35199204-FE2590F7-919B-44CA-BE81-048D7CBCE0FDQ35639937-16F8270D-A7F3-48E0-8A34-45632812C478Q35676767-BBCDEE6C-ABB0-4C82-AE66-90A01E0B9DB4Q35971460-C41E2C51-574F-4279-8091-A6BA61AC519FQ36155500-20695ECA-117E-4AA6-BC1F-54ACCF95D419Q36191698-62C02867-4CD9-4157-B793-A4E8FD496B8AQ36270144-0912D92F-06FA-4FBD-A435-A49A5E79DE2FQ36334968-F7B795FF-4055-4C80-B894-22DC66B96E12Q36421322-FF5868DF-09D4-4A3A-A30C-0286DD08B41BQ36453553-087F4BA7-C73A-4BBD-BC21-62432EC5E26BQ36463365-34D329A6-FE8B-40D8-97B7-EF266D963393Q36516772-519B7083-81BE-44A5-9AD0-26163C334221Q36545726-8A49E65E-B8B0-45D4-BEF1-269C6E9A53CFQ36713398-D197BA2B-373B-4F1E-B58A-2B70341735D6Q36732473-5FFBCB78-9402-4489-89C7-4A87CA2CF268Q36744575-8E616A9A-7AF4-4A71-A131-194308E1BBBEQ36850742-1FBACC88-0891-4B5C-BDF1-CB5AE1309EA1Q36997854-03C5760A-C08B-43A1-9E1C-3F1C7A9DA311Q37175201-1458F6FE-0A60-43E5-B4EF-0DE4F6F02AF6Q37302759-E2A3E652-4312-4771-9DB6-2FB958F4265CQ37421689-E7EF1475-BCD7-48E0-B8CD-72D3856225CBQ37428647-7D5EE137-5C27-4D5F-94A1-721D40438682Q37496657-440DB9BB-3486-445B-9464-A192A8D9FAD7Q37565664-3F9B5982-486B-4106-BA9B-545D3608E5ACQ37999067-32C70229-A0D6-4285-8AFF-764C55682CB8Q38072052-4991C52D-10F2-4ED5-B5A9-DEC1887E59E9
P2860
Phosphorylation of PML by mitogen-activated protein kinases plays a key role in arsenic trioxide-mediated apoptosis.
description
2004 nî lūn-bûn
@nan
2004 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Phosphorylation of PML by mito ...... c trioxide-mediated apoptosis.
@ast
Phosphorylation of PML by mito ...... c trioxide-mediated apoptosis.
@en
Phosphorylation of PML by mito ...... c trioxide-mediated apoptosis.
@nl
type
label
Phosphorylation of PML by mito ...... c trioxide-mediated apoptosis.
@ast
Phosphorylation of PML by mito ...... c trioxide-mediated apoptosis.
@en
Phosphorylation of PML by mito ...... c trioxide-mediated apoptosis.
@nl
prefLabel
Phosphorylation of PML by mito ...... c trioxide-mediated apoptosis.
@ast
Phosphorylation of PML by mito ...... c trioxide-mediated apoptosis.
@en
Phosphorylation of PML by mito ...... c trioxide-mediated apoptosis.
@nl
P1433
P1476
Phosphorylation of PML by mito ...... c trioxide-mediated apoptosis.
@en
P2093
Fumihiko Hayakawa
Martin L Privalsky
P304
P356
10.1016/S1535-6108(04)00082-0
P577
2004-04-01T00:00:00Z